Ella Zomer
- Geriatrics and Gerontology top 0.5%
- Pharmaceutical Practices and Patient Outcomes 10
- Family Practice top 2%
- Economics and Econometrics top 1%
- Health Systems, Economic Evaluations, Quality of Life 43
- Pharmaceutical Economics and Policy 15
-
- Diabetes Treatment and Management 12
- Diabetes, Cardiovascular Risks, and Lipoproteins 9
-
- Lipoproteins and Cardiovascular Health 26
-
- Global Health Care Issues 11
-
- Global Public Health Policies and Epidemiology 8
- Co-authors
- Danny LiewZanfina AdemiRichard Ofori‐AsensoAlice OwenSophia ZoungasKen Lee ChinIlana N. AckermanAndrea J. Curtis
- Journals
- SHILAP Revista de lepidopterología (2 papers)PLoS ONE (2 papers)Neurology (1 paper)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Ella Zomer
112 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Geriatrics and Gerontology 492
- Family Practice 113
- Economics and Econometrics 718
- Endocrinology, Diabetes and Metabolism 374
- Cardiology and Cardiovascular Medicine 488
Countries citing papers authored by Ella Zomer
This map shows the geographic impact of Ella Zomer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ella Zomer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ella Zomer more than expected).
Fields of papers citing papers by Ella Zomer
This network shows the impact of papers produced by Ella Zomer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ella Zomer. The network helps show where Ella Zomer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ella Zomer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 10 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 44 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 16 | |
| 11 | 2021 | 33 | |
| 12 | 2021 | 12 | |
| 13 | 2020 | 15 | |
| 14 | 2020 | 12 | |
| 15 | 2020 | 31 | |
| 16 | 2020 | 27 | |
| 17 | 2020 | 18 | |
| 18 | 2018 | 22 | |
| 19 | 2017 | 3 | |
| 20 | Urotensin II is a vasoconstrictor in diabetic patients without heart failure or essential hypertension | 2006 | 1 |
About Ella Zomer
Ella Zomer is a scholar working on Family Practice, Geriatrics and Gerontology and Economics and Econometrics, having authored 114 papers that have together received 2.8k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (43 papers), Lipoproteins and Cardiovascular Health (26 papers), Pharmaceutical Economics and Policy (15 papers), Diabetes Treatment and Management (12 papers), Global Health Care Issues (11 papers), Pharmaceutical Practices and Patient Outcomes (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Global Public Health Policies and Epidemiology (8 papers). The work is most often cited by research in Geriatrics and Gerontology (492 citations), Family Practice (113 citations) and Economics and Econometrics (718 citations). Ella Zomer has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Danny Liew, Zanfina Ademi, Richard Ofori‐Asenso, Alice Owen, Sophia Zoungas, Ken Lee Chin, Ilana N. Ackerman, Andrea J. Curtis, Mark Tacey and Jenni Ilomäki. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.